Repare Therapeutics
RPTX
RPTX was delisted on the 27th of January, 2026.
45 hedge funds and large institutions have $48M invested in Repare Therapeutics in 2025 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 7 reducing their positions, and 9 closing their positions.
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
24% more capital invested
Capital invested by funds: $38.6M → $48M (+$9.42M)
1.22% less ownership
Funds ownership: 64.7% → 63.49% (-1.2%)
10% less funds holding
Funds holding: 50 → 45 (-5)
14% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 7
56% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RC
Rangeley Capital
New Canaan,
Connecticut
|
+$465K |
| 2 |
Renaissance Technologies
New York
|
+$322K |
| 3 |
Squarepoint
New York
|
+$104K |
| 4 |
LWA
Lantern Wealth Advisors
Melville,
New York
|
+$32K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$22.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$567K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$381K |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
-$181K |
| 4 |
NAMA
Nikko Asset Management Americas
New York
|
-$162K |
| 5 |
Sumitomo Mitsui Trust Group
Minato-Ku, Tokyo,
Japan
|
-$162K |
RPTX Hedge Fund Activity: Q3 2025 in Review
45 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in Repare Therapeutics (RPTX) for Q3 2025, worth a combined $48M — up 24% from $38.6M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of RPTX and 4 opened new positions — a net loss of 5 holders — while 7 trimmed existing stakes and 6 added.
The largest buyer was Rangeley Capital, adding an estimated $465K. The largest seller was Millennium Management, exiting entirely with an estimated $567K sold.
- 45 institutional investors held Repare Therapeutics (RPTX) as of Q3 2025, down from 50 in Q2 2025.
- Funds reported $48M of Repare Therapeutics stock for Q3 2025, up 24% quarter-over-quarter.
- 4 funds opened new Repare Therapeutics positions in Q3 2025 and 9 closed out, a net change of -5 holders.
- The largest Repare Therapeutics buyer in Q3 2025 was Rangeley Capital, an estimated $465K added.
- The largest Repare Therapeutics seller in Q3 2025 was Millennium Management, an estimated $567K sold.
Based on aggregated 13F filings for Q3 2025.